Home » Topics » BioWorld Science

BioWorld Science
RSS

Tsinghua University synthesizes new NAMPT enzyme activators

July 20, 2022

Galecto Biotech identifies new LGALS inhibitors

July 20, 2022

Praxis Precision Medicines discloses KCNT1 inhibitors

July 20, 2022

Korean investigators divulge new EGFR inhibitors

July 20, 2022

Jiangsu Hengrui Medicine patents PTPN11 inhibitors

July 20, 2022

Novel CDK9 inhibitor with good antiproliferative activity in hematologic cancer models

July 20, 2022

AZD-1390 induces dramatic recovery after spinal cord injury in preclinical models

July 20, 2022

Hepsin contributes to metastasis and thrombosis in patients with CRC, study finds

July 20, 2022

Novel HDAC3 inhibitor shows antitumor activity in 4T1-Luc xenograft mouse model

July 19, 2022

Researchers unveil novel markers involved in pulmonary embolism

July 19, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...